OtherBASIC SCIENCE INVESTIGATIONS
Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET
Jeffrey R. Tseng, Keon Wook Kang, Mangal Dandekar, Shahriar Yaghoubi, Joseph H. Lee, James G. Christensen, Stephen Muir, Patrick W. Vincent, Neil R. Michaud and Sanjiv S. Gambhir
Journal of Nuclear Medicine January 2008, 49 (1) 129-134; DOI: https://doi.org/10.2967/jnumed.106.038836
Jeffrey R. Tseng
Keon Wook Kang
Mangal Dandekar
Shahriar Yaghoubi
Joseph H. Lee
James G. Christensen
Stephen Muir
Patrick W. Vincent
Neil R. Michaud
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue 1
January 2008
Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET
Jeffrey R. Tseng, Keon Wook Kang, Mangal Dandekar, Shahriar Yaghoubi, Joseph H. Lee, James G. Christensen, Stephen Muir, Patrick W. Vincent, Neil R. Michaud, Sanjiv S. Gambhir
Journal of Nuclear Medicine Jan 2008, 49 (1) 129-134; DOI: 10.2967/jnumed.106.038836
Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET
Jeffrey R. Tseng, Keon Wook Kang, Mangal Dandekar, Shahriar Yaghoubi, Joseph H. Lee, James G. Christensen, Stephen Muir, Patrick W. Vincent, Neil R. Michaud, Sanjiv S. Gambhir
Journal of Nuclear Medicine Jan 2008, 49 (1) 129-134; DOI: 10.2967/jnumed.106.038836
Jump to section
Related Articles
Cited By...
- Influence of Animal Heating on PET Imaging Quantification and Kinetics: Biodistribution of 18F-Tetrafluoroborate and 18F-FDG in Mice
- VEGFR2-Targeted Three-Dimensional Ultrasound Imaging Can Predict Responses to Antiangiogenic Therapy in Preclinical Models of Colon Cancer
- Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma
- Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects
- 3'-Deoxy-3'-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
- Differential 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
- Modulating Tumor Vasculature through Signaling Inhibition to Improve Cytotoxic Therapy
- Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin
- Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
- Introduction